Fr. 106.00

Talking Points on Deprescribing in Hospice Care

Inglese · Copertina rigida

Spedizione di solito entro 3 a 5 settimane

Descrizione

Ulteriori informazioni










Deprescribing practice in hospice medicine has expanded exponentially in recent years. This book systematically addresses the groups of extremely useful medications to manage chronic disease conditions and prevent complications.


Sommario










  1. Introduction
  2. Physiologic changes of terminal illness
  3. Fundamentals of deprescribing
  4. Deprescribing Statins
  5. Deprescribing Benzodiazepines
  6. Deprescribing Antipsychotics
  7. Deprescribing SSRI and SNRIs
  8. Deprescribing Tricyclic Antidepressants
  9. Deprescribing Anticholinergic drugs for parkinsonism
  10. Deprescribing Anticholinergic drugs for urinary incontinence
  11. Deprescribing muscle relaxants
  12. Deprescribing long-term Opioids
  13. Deprescribing Proton Pump Inhibitors
  14. Deprescribing Allopurinol
  15. Deprescribing Antihyperglycemics Oral
  16. Deprescribing Antihyperglycemics Injectable
  17. Deprescribing anti-hypertensives
  18. Deprescribing Anticoagulants
  19. Deprescribing Cholinesterase inhibitors
  20. Deprescribing Glaucoma eye drops
  21. Deprescribing Vitamin D and Calcium
  22. Deprescribing NSAIDs
  23. Deprescribing gabapentin and pregabalin
  24. Deprescribing long-acting Beta agonist
  25. Deprescribing Vitamins
  26. Deprescribing medications in children
  27. Deprescribing in Transgender and LGBTQ
  28. Cultural competency in deprescribing
  29. Chaplain and medical social worker
  30. When to restart discontinued medications.
  31. Medicolegal aspects of deprescribing


Info autore










Deepak Shrivastava, MD is a board-certified Hospice Medical Director. In addition, he holds board certifications in Internal Medicine, Sleep Medicine, Pulmonary and Critical Care Medicine and Post-Acute and Long-Term Care. He is an academic and clinical faculty at the Sleep, Critical Care and Pulmonary division. He is a Clinical Professor at the University of California. He is an adjunct Professor of Pharmacy at the University of Pacific, School of Pharmacy. He is the recipient of many academic and service awards including the Medical Director of the Year award (2015) at the American Medical Directors Association. Dr. Shrivastava received his training at the State University of New York, University of California, Davis and Stanford. He is an active researcher with a keen interest in medical education. He is directly involved in health care quality and performance improvement. In addition to his active practice of Pulmonary, Critical Care and Sleep Medicine in an ACGME-accredited teaching program, he has been involved in Medicare Hospice Benefit Program since 1989. He is a member of the National Partnership for Healthcare and Hospice Innovation (NPHI). His areas of interest are clinical nursing and hospice physician education, and performance improvement in hospice care.


Riassunto

Deprescribing practice in hospice medicine has expanded exponentially in recent years. This book systematically addresses the groups of extremely useful medications to manage chronic disease conditions and prevent complications.

Recensioni dei clienti

Per questo articolo non c'è ancora nessuna recensione. Scrivi la prima recensione e aiuta gli altri utenti a scegliere.

Scrivi una recensione

Top o flop? Scrivi la tua recensione.

Per i messaggi a CeDe.ch si prega di utilizzare il modulo di contatto.

I campi contrassegnati da * sono obbligatori.

Inviando questo modulo si accetta la nostra dichiarazione protezione dati.